Mr. Lefton assists the Frazier Growth Buyout team in identifying, evaluating, acquiring, and advising healthcare services companies.
Mr. Lefton was Co-founder, Executive Chairman, and a Director of DSI Renal, a Frazier portfolio company which merged with U.S. Renal Care. He currently remains on the board of U.S Renal Care and serves as Executive Chairman for United Derm Partners, another Frazier portfolio company.
Prior to DSI, Mr. Lefton served as President, CEO, and Director of Odyssey Healthcare, then the largest publicly-traded hospice service provider. Prior to Odyssey, he co-founded SemperCare, an operator of long-term acute care hospitals, and served as President and CEO until the sale of the company to Select Medical. Earlier, he served in various capacities at Horizon Health Corporation, a provider of behavioral health services, including as President and Chief Operating Officer.
Mr. Lefton previously served as a director of MedMark Services, Medical Staffing Networks (MSN), Sheridan Healthcare, Accuro Healthcare Solutions, Horizon Health Corporation, Signature Hospital Corporation, Pathology Partners, and Solis Women's Health.
Tulane University (B.A., M.B.A., M.P.H.)